...
机译:肺癌中EML4-ALK和其他ALK融合基因的检测:来自白血病融合基因分析的课程和未来应用
Department of Laboratory Medicine School of Medicine Kyung Hee University Seoul South Korea;
Department of Laboratory Medicine School of Medicine Kyung Hee University Seoul South Korea;
Department of Laboratory Medicine School of Medicine Kyung Hee University Seoul South Korea;
Department of Hematology-Oncology School of Medicine Kyung Hee University Seoul South Korea;
Department of Hematology-Oncology School of Medicine Kyung Hee University Seoul South Korea;
Green Cross Reference Laboratory Yongin South Korea;
Institute of Pharmaceutical Biology ZAFES Diagnostic Center of Acute Leukemia Goethe-University;
Institute of Pharmaceutical Biology ZAFES Diagnostic Center of Acute Leukemia Goethe-University;
机译:致编辑的信:肺癌中EML4-ALK和其他ALK融合基因的检测:白血病融合基因分析和未来应用的教训
机译:在使用支气管内超声引导的经支气管针抽吸EML4-ALK融合基因检测后,用ALK抑制剂治疗肺癌。
机译:具有EGFR突变相关临床特征的非小细胞肺癌患者EML4-ALK融合基因的检测
机译:RNA测序在甲状腺癌患者中的诊断应用:524基因851种变体和133次融合的分析
机译:ROS1融合的基于本地化的信号通路依赖性和在EML4-ALK驱动的肺癌中Ras的新作用。
机译:致编辑的信:肺癌中EML4-ALK和其他ALK融合基因的检测:白血病融合基因分析和未来应用的教训
机译:致编辑的信:肺癌中EML4-ALK和其他ALK融合基因的检测:白血病融合基因分析和未来应用的教训